✦ LIBER ✦

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or nonsquamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

✍ Scribed by A. Santin; G. Patricia; M. Sill; D. McMeekin; M. Leitao; J. Brown; G. Sutton; L. Van Le; C. Boardman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of cetuximab in the treat

✍ Alessandro D. Santin; Michael W. Sill; D. Scott McMeekin; Mario M. Leitao Jr.; J 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 342 KB

Evaluation of tamoxifen in persistent or

✍ L. R. Bigler; J. Tate Thigpen; J. A. Blessing; J. Fiorica; B. J. Monk 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Evaluation of vinorelbine in persistent

✍ Franco M. Muggia; John A. Blessing; Steven Waggoner; Jonathan S. Berek; Bradley 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Evaluation of vinorelbine in persistent

✍ Franco M Muggia; John A Blessing; Michael Method; David Scott Miller; Gary A Joh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Phase II clinical trial of capecitabine

✍ Agustin A. Garcia; John A. Blessing; Kathleen M. Darcy; Heinz Josef Lenz; Wu Zha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II Trial of Topotecan and Cisplati

✍ J. Fiorica; R. Holloway; B. Ndubisi; J. Orr; E. Grendys; R. Boothby; S. DeCesare 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 80 KB